S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

GPCR Structure Therapeutics Inc

22.00

-0.34 (-1.52%)

Pre Market

Last Updated: 00:45:32

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Structure Therapeutics (NASDAQ:GPCR)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Structure Therapeutics Charts.

Structure Therapeutics (NASDAQ:GPCR)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Structure Therapeutics Charts.

Structure Therapeutics Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 28 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 28 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (5 days ago) • Edgar (US Regulatory)

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
Friday 28 February 2025 (5 days ago) • GlobeNewswire Inc.

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
Friday 31 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 18 December 2024 (3 months ago) • Edgar (US Regulatory)

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Wednesday 18 December 2024 (3 months ago) • GlobeNewswire Inc.

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
Saturday 16 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
Thursday 14 November 2024 (4 months ago) • GlobeNewswire Inc.

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
Thursday 14 November 2024 (4 months ago) • GlobeNewswire Inc.

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
Thursday 31 October 2024 (4 months ago) • GlobeNewswire Inc.

More Structure Therapeutics Inc News Articles

BNP Paribas Issuance

ST Microelectronics

Gencor Industries

Innovator Premium Income...

BNP PARIBAS ISSUANCE

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions